Adaptive Biotechnologies to Report Second Quarter Financial Results on August 13, 2019
August 01 2019 - 4:15PM
Adaptive Biotechnologies (Nasdaq: ADPT) today announced that it
will report financial results for the second quarter of 2019 after
market close on Tuesday, August 13, 2019. Company management will
host a corresponding conference call, beginning at 1:30 p.m.
Pacific Time (4:30 p.m. Eastern Time).
Investors interested in listening to the
conference call may do so by dialing (800) 361-2311 for U.S.
callers or (409) 937-8761 for international callers (Conference ID:
3095467). The webcast can be accessed at
http://investors.adaptivebiotech.com.
Within 24 hours of the webcast, a replay will be
available by clicking on the Events link at
http://investors.adaptivebiotech.com.
About Adaptive
Biotechnologies
Adaptive Biotechnologies is a
commercial-stage biotech company focused on harnessing the inherent
biology of the adaptive immune system to transform the diagnosis
and treatment of disease. We believe the adaptive immune system is
nature’s most finely tuned diagnostic and therapeutic for most
diseases, but the inability to decode it has prevented the medical
community from fully leveraging its capabilities. Our proprietary
immune medicine platform reveals and translates the massive
genetics of the adaptive immune system with scale, precision and
speed to develop products in life sciences research, clinical
diagnostics, and drug discovery. We have two commercial products,
and a robust clinical pipeline to diagnose, monitor and enable the
treatment of diseases such as cancer, autoimmune conditions and
infectious diseases. Our goal is to develop and commercialize
immune-driven clinical products tailored to each individual
patient. For more information, please visit:
adaptivebiotech.com.
Investor Contact:
Lynn Lewis or Carrie
Mendivilinvestors@adaptivebiotech.com
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Adaptive Biotechnologies (NASDAQ:ADPT)
Historical Stock Chart
From Sep 2023 to Sep 2024